Sionna Therapeutics, Inc. Common Stock (SION) — Financial Flexibility Index
Sionna Therapeutics, Inc. Common Stock (SION) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-16.42 Million (operating CF $-16.63 Million minus capex $204.00K) represents -1% of total liabilities ($19.12 Million). Check asset allocation strategy of Sionna Therapeutics, Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sionna Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Sionna Therapeutics, Inc. Common Stock across 4 annual periods. See Sionna Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sionna Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Sionna Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see market cap of Sionna Therapeutics, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.45x | $-65.92 Million | $-66.30 Million | $19.12 Million | ▼ -2183.6% |
| 2024 | -0.15x | $-52.76 Million | $-52.79 Million | $349.46 Million | ▲ +40.9% |
| 2023 | -0.26x | $-42.58 Million | $-43.70 Million | $166.83 Million | ▼ -17.4% |
| 2022 | -0.22x | $-34.19 Million | $-36.07 Million | $157.29 Million | — |